Table 3.
Correlation between clinicopathological features and stage progression in 118 cases of high grade non-muscle invasive bladder cancer
| Variables | Cases without progression | Cases with progression | P-value | |
|---|---|---|---|---|
| Sex | Male | 88 (88.0) | 16 (88.9) | > 0.999 |
| Female | 12 (12.0) | 2 (11.1) | ||
| Multiplicity | Absence | 47 (47.0) | 4 (22.2) | 0.070 |
| Presence | 53 (53.0) | 14 (77.8) | ||
| Tumor size (cm) | < 1.5 | 14 (15.7) | 2 (13.3) | 0.494 |
| 1.5-3 | 39 (43.8) | 9 (60.0) | ||
| > 3 | 36 (40.5) | 4 (26.7) | ||
| pT stage | Ta | 14 (14.0) | 3 (16.7) | 0.723 |
| T1 | 86 (86.0) | 15 (83.3) | ||
| Invasive component (%) | ≤ 50 | 75 (75.0) | 9 (50.0) | 0.046 |
| > 50 | 25 (25.0) | 9 (50.0) | ||
| Carcinoma in situ | Absence | 67 (67.0) | 12 (66.7) | > 0.999 |
| Presence | 33 (33.0) | 6 (33.3) | ||
| Lymphovascular invasion | Absence | 99 (98.3) | 17 (94.4) | 0.283 |
| Presence | 1 (1.0) | 1 (5.6) |